Mirexus Biotechnologies Inc. (MBI) is pleased to announce the appointment of Boris Segalowich as President of Mirexus Inc. Mirexus Inc. is a wholly owned subsidiary company of MBI, and is focused on applications of it’s unique, plant-based active ingredient PhytoSpherix® in the personal care industry. “Boris joined as VP Personal Care in June this year… Read more Boris Segalowich appointed as President of Mirexus Inc.
On Thursday, September 28th Mirexus Biotechnologies hosted a ground-breaking ceremony to celebrate the commencement of construction of its new manufacturing and research facility in Guelph. The building will include expanded lab space and offices, and most importantly a first-generation factory, designed to produce 16T / year of PhytoSpherix™ – Mirexus’ safe & natural nanomaterial. The… Read more Mirexus Biotechnologies celebrated ground-breaking for new manufacturing facility
The Board of Directors of Mirexus are pleased to announce the promotion of Alison Crumblehulme to Vice President Business Development. Alison started her career in R&D and then moved into business development while doing an MBA at Queen’s – before joining Mirexus ~2 years ago to lead our Business Development efforts. “Alison has quickly become… Read more Alison Crumblehulme Promoted to Vice President Business Development